Schlieren / Zurich, Switzerland, 11 June, 2025 – Memo Therapeutics AG (or “MTx”), a late-stage biotechnology company developing antibody-based therapies for viral infections and cancer, has published ...

1 Centre for Critical Illness Research, Lawson Health Research Institute; 2 Division of Respirology, 3 Department of Medicine, 4 Department of Physiology and Pharmacology, Schulich School of Medicine ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

After beefing up its presence in cardiovascular and renal pharmacology in August, Inotiv is doubling down in those and other areas with its $15 million acquisition of Plato BioPharma. The Indiana ...

Inotiv is boosting its lab support services in cardiovascular and renal pharmacology, and CenExel Clinical Research is beefing up its dermatology capabilities. That's what two newly announced ...

APS (Acta Pharmacologica Sinica) publishes high quality content in all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer ...

Results demonstrate that intravenously administered therapeutic IgG antibodies can be detected in urine, supporting the conclusion that these antibodies are capable of crossing the kidney endothelial ...